No provider communication You should have a way to communicate with your prescribing provider, not just customer support staff, throughout your treatment
| | | | | | | GLP-1 Receptor Agonists 2 GLP-1 Receptor Agonists (GLP-1 RAs) (Incretin Mimetic) GLP-1 (Glucagon-like Peptide-1) GLP-1 2 GLP-1 RAs : : Liraglutide (Victoza, Saxenda), Exenatide (Byetta) : Semaglutide (Ozempic, Wegovy), Dulaglutide (Trulicity), Exenatide Extended-Release (Bydureon BCise) : Semaglutide (Rybelsus) GLP-1 RAs : GLP-1 Receptor Agonists GLP-1 : : : (Glucagon) (Gastric Emptying): : GLP-1 Receptor Agonists : 2 (Type 2 Diabetes Mellitus): ( Metformin) (Weight Management): GLP-1 RAs Liraglutide (Saxenda) Semaglutide (Wegovy) : (Major Adverse Cardiovascular Events - MACE) 2 GLP-1 Receptor Agonists : : (pre-filled pen) (Subcutaneous Injection) Liraglutide: (Daily) Semaglutide, Dulaglutide, Exenatide ER: (Weekly) : Semaglutide (Rybelsus) 30 ( 120
Goal: moderate weight loss (10 to 15% of body weight) If your target is 10 to 15% body weight reduction, you may not need to escalate beyond 4 to 8 mg
This may mean evaluating menopause symptoms and risks, not hormones for everyone If GLP 1 is used, pair it with muscle protective behaviors and a maintenance strategy from day one For many patients, the goal is to rebalance hormones for weight loss while also stabilizing energy, cravings, and sleep
For individuals who often feel fatigued or lethargic, these injections can provide a much-needed boost
Figure 1 Figure 2 3 Mechanisms of action for GLP-1R agonists to control food intake GLP-1R agonists primarily act to reduce body weight by suppressing energy intake